Keystone Wealth Partners

SEC CIK: 0001845980
Latest filing: Apr 29, 2022

SEC filings (opens in a new tab)

AVXL holding history

Anavex Life Sciences Corp. in every 13F filed by Keystone Wealth Partners, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVXL overview All 13F holders of AVXL Full Q1 2022 holdings

Shares (Q3 2021): 0; Sold out in Q3 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2021

Holdings of AVXL by Keystone Wealth Partners, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2021	0	$0	0.0%	−9,950−100.0%	Sold out	Holders
Q2 2021	9,950	$227.0K	0.1%	−700−6.6%	Reduced	Holders
Q1 2021	10,650	$159.0K	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.